Pharmacological validation of Solanum mammosum L. as an anti-infective agent: Role of solamargine

dc.contributor.authorCabanillas, Billy
dc.contributor.authorChassagne, François
dc.contributor.authorVásquez Ocmín, Pedro
dc.contributor.authorTahrioui, Ali
dc.contributor.authorChevalier, Sylvie
dc.contributor.authorVansteelandt, Marieke
dc.contributor.authorTriastuti, Asih
dc.contributor.authorAmasifuen Guerra, Carlos Alberto
dc.contributor.authorFabre, Nicolas
dc.contributor.authorHaddad, Mohamed
dc.coverage.spatialPerúes_PE
dc.date.accessioned2021-08-11T22:48:20Z
dc.date.available2021-08-11T22:48:20Z
dc.date.issued2021-07-31
dc.description.abstractEthnopharmacological relevance: Fungal and bacterial infections remain a major problem worldwide, requiring the development of effective therapeutic strategies. Solanum mammosum L. (Solanaceae) (“teta de vaca”) is used in traditional medicine in Peru to treat fungal infections and respiratory disorders via topical application. However, the mechanism of action remains unknown, particularly in light of its chemical composition. Materials and methods: The antifungal activity of TDV was determined against Trichophyton mentagrophytes and Candida albicans using bioautography-TLC-HRMS to rapidly identify the active compounds. Then, the minimum inhibitory concentration (MIC) of the fruit crude extract and the active compound was determined to precisely evaluate the antifungal activity. Additionally, the effects of the most active compound on the formation of Pseudomonas aeruginosa biofilms and pyocyanin production were evaluated. Finally, a LC-HRMS profile and a molecular network of TDV extract were created to characterize the metabolites in the fruits' ethanolic extract. Results: Bioautography-TLC-HRMS followed by isolation and confirmation of the structure of the active compound by 1D and 2D NMR allowed the identification solamargine as the main compound responsible for the anti-Trichophyton mentagrophytes (MIC = 64 μg mL−1) and anti-Candida albicans (MIC = 64 μg mL−1) activities. In addition, solamargine led to a significant reduction of about 20% of the Pseudomonas aeruginosa biofilm formation. This effect was observed at a very low concentration (1.6 μg mL−1) and remained fairly consistent regardless of the concentration. In addition, solamargine reduced pyocyanin production by about 20% at concentrations of 12.5 and 50 μg mL−1. Furthermore, the LC-HRMS profiling of TDV allowed us to annotate seven known compounds that were analyzed through a molecular network. Conclusions: Solamargine has been shown to be the most active compound against T. mentoagrophytes and C. albicans in vitro. In addition, our data show that this compound affects significantly P. aeruginosa pyocyanin production and biofilm formation in our conditions. Altogether, these results might explain the traditional use of S. mammosum fruits to treat a variety of fungal infections and respiratory disorders.es_PE
dc.description.tableofcontentsAbstract. 1. Introduction. 2. Material and methods. 3. Results. 4. Discussion. 5. Conclusion. Referenceses_PE
dc.formatapplication/pdfes_PE
dc.identifier.citationCabanillas, B.; Chassagne, F.; Vásquez, P.; Tahrioui, A.; Chevalier, S.; Vansteelandt, M.; Trastuti, A.; Amasifuen, C.; Fabre, N. & Haddad, M. (2021). Pharmacological validation of Solanum mammosum L. as an anti-infective agent: Role of solamargine, Journal of Ethnopharmacology Volume 280, 114473. doi: 10.1016/j.jep.2021.114473.es_PE
dc.identifier.doihttps://doi.org/10.1016/j.jep.2021.114473
dc.identifier.journalJournal of Ethnopharmacologyes_PE
dc.identifier.urihttps://hdl.handle.net/20.500.12955/1427
dc.language.isoenges_PE
dc.publisherEl Sevieres_PE
dc.publisher.countryReino Unidoes_PE
dc.relation.ispartofJournal of Ethnopharmacology 280 (2021) 114473es_PE
dc.relation.publisherversionhttps://doi.org/10.1016/j.jep.2021.114473es_PE
dc.rightsinfo:eu-repo/semantics/openAccesses_PE
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/es_PE
dc.sourceInstituto Nacional de Innovación Agrariaes_PE
dc.source.uriRepositorio Institucional - INIAes_PE
dc.subjectSolanum mammosumes_PE
dc.subjectCandida albicanses_PE
dc.subjectTrichophyton mentagrophyteses_PE
dc.subjectPseudomonas acruginosaes_PE
dc.subjectBioautographyes_PE
dc.subjectSolamarginees_PE
dc.subjectLC-HRMSes_PE
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#4.04.02es_PE
dc.titlePharmacological validation of Solanum mammosum L. as an anti-infective agent: Role of solamarginees_PE
dc.typeinfo:eu-repo/semantics/articlees_PE

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
Cabanillas-et-al_2021_Solanum Mammosum_L..pdf
Tamaño:
2.13 MB
Formato:
Adobe Portable Document Format

Bloque de licencias

Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:

Sede Central: Av. La Molina 1981 - La Molina. Lima. Perú - 15024

Central telefónica (511) 240-2100 / 240-2350

FacebookLa ReferenciaEurocris
Correo: repositorio@inia.gob.pe

© Instituto Nacional de Innovación Agraria - INIA